Monitoring Radiographic Brain Tumor Progression

Toxins

Ankit I. Mehta¹  Charles W. Kanaly²  Allan H. Friedman²  Darell D. Bigner² 

[1] Division of Neurosurgery, Duke University Medical Center, Box 3807, Durham, NC 27710, USA;

关键词: glioblastoma;    radiographic progression;    tumor progression;    MRI;   

DOI  :  10.3390/toxins3030191

来源: mdpi

【 摘 要 】

Determining radiographic progression in primary malignant brain tumors has posed a significant challenge to the neuroncology community. Glioblastoma multiforme (GBM, WHO Grade IV) through its inherent heterogeneous enhancement, growth patterns, and irregular nature has been difficult to assess for progression. Our ability to detect tumor progression radiographically remains inadequate. Despite the advanced imaging techniques, detecting tumor progression continues to be a clinical challenge. Here we review the different criteria used to detect tumor progression, and highlight the inherent challenges with detection of progression.

【 授权许可】

CC BY   
© 2011 by the authors; licensee MDPI, Basel, Switzerland.